or
forgot password

    • cancer clinical trials in boston, MA

    • Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Unspecified Adult Solid Tumor, Protocol Specific
    Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
    Cancer Research Center at Boston Medical Center
    Boston, Massachusetts 02118
    Multiple Myeloma and Plasma Cell Neoplasm
    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Floating Hospital for Children at Tufts - New England Medical Center

    Trial Locations
    Floating Hospital for Children at Tufts - New England Medical Center
    Massachusetts General Hospital
    Leukemia
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    DFCI/Brigham & Women's
    Boston, Massachusetts 02114
    Multiple Myeloma
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Tufts-NEMC Cancer Center
    Boston, Massachusetts 02111
    Lymphoma
    Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130
    Healthy
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Metastatic Cancer, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Boston Medical Center
    Brigham and Women's Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Breast Cancer
    Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Partners Cancer Care
    Lung Cancer
    Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Cancer Research Center at Boston Medical Center
    Dana-Farber/Brigham and Women's Cancer Center
    Head and Neck Cancer
    Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Melanoma (Skin)
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Leukemia
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Brain Tumor, Central Nervous System Tumor
    Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
    Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Chronic Lymphocytic Leukemia
    Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts 02114
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Tufts-New England Medical Center, The Neeley Center for Clinical Research
    Boston, Massachusetts 02111
    Pancreatic Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Floating Hospital for Children
    Kidney Cancer
    Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Head and Neck Cancer
    Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Head and Neck Cancer
    Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
    Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Breast Cancer
    Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Head and Neck Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Boston University Cancer Research Center
    Breast Cancer
    Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Harvard Cancer Center
    Insular Thyroid Cancer, Recurrent Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer